Unveiling the Solvent Effect: DMSO Interaction with Human Nerve Growth Factor and Its Implications for Drug Discovery
Molecules · 2025
DOI: 10.3390/molecules30143030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Francesca Paoletti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Crystallography-C.N.R.-Trieste Outstation, 34149 Trieste, Italy. Hauptthemen laut MEDLINE: Dimethyl Sulfoxide, Nerve Growth Factor, Solvents, Drug Discovery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CERIC-ERIC, Next Generation EU, ARIS.
Abstract (Originalsprache)
Background
The Nerve Growth Factor (NGF) is essential for neuronal survival and function and represents a key therapeutic target for pain and inflammation-related disorders, as well as for neurodegenerative diseases. Small-molecule antagonists of human NGF (hNGF) offer advantages over monoclonal antibodies, including oral availability and reduced immunogenicity. However, their development is often hindered by solubility challenges, necessitating the use of solvents like dimethyl sulfoxide (DMSO). This study investigates whether DMSO directly interacts with hNGF and affects its receptor-binding properties.
Methods
Integrative/hybrid computational and experimental biophysical approaches were used to assess DMSO-NGF interaction by combining machine-learning tools and Nuclear Magnetic Resonance (NMR), Fourier Transform Infrared (FT-IR) spectroscopy, Differential Scanning Fluorimetry (DSF) and Grating-Coupled Interferometry (GCI). These techniques evaluated binding affinity, conformational stability, and receptor-binding dynamics.
Results
Our findings demonstrate that DMSO binds hNGF with low affinity in a specific yet non-disruptive manner. Importantly, DMSO does not induce significant conformational changes in hNGF nor affect its interactions with its receptors.
Conclusions
These results highlight the importance of considering solvent–protein interactions in drug discovery, as these low-affinity yet specific interactions can affect experimental outcomes and potentially alter the small molecules binding to the target proteins. By characterizing DMSO-NGF interactions, this study provides valuable insights for the development of NGF-targeting small molecules, supporting their potential as effective alternatives to monoclonal antibodies for treating pain, inflammation, and neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Crystallography-C.N.R.-Trieste Outstation, 34149 Trieste, Italy.
- Laboratory for Molecular Structural Dynamics, Theory Department, National Institute of Chemistry, 1001 Ljubljana, Slovenia.
- Interuniversity Consortium "Biostructures and Biosystems National Institute", 00136 Rome, Italy.
ORCID-Profile: Tjaša Goričan, Alberto Cassetta, Jože Grdadolnik, Doriano Lamba, Simona Golič Grdadolnik
Förderung
- CERIC-ERIC
- Next Generation EU
- ARIS
- PNRR (Italian National Recovery and Resilience Plan)
Zitieren
APA
Paoletti, F., Goričan, T., Cassetta, A., Grdadolnik, J., Toporash, M., Lamba, D., Golič Grdadolnik, S., & Covaceuszach, S. (2025). Unveiling the Solvent Effect: DMSO Interaction with Human Nerve Growth Factor and Its Implications for Drug Discovery. Molecules. https://doi.org/10.3390/molecules30143030
Vancouver
Paoletti F, Goričan T, Cassetta A, Grdadolnik J, Toporash M, Lamba D, et al. Unveiling the Solvent Effect: DMSO Interaction with Human Nerve Growth Factor and Its Implications for Drug Discovery. Molecules. 2025. doi:10.3390/molecules30143030
BibTeX
@article{Paoletti2025,
author = {Paoletti, Francesca and Goričan, Tjaša and Cassetta, Alberto and Grdadolnik, Jože and Toporash, Mykola and Lamba, Doriano and Golič Grdadolnik, Simona and Covaceuszach, Sonia},
title = {Unveiling the Solvent Effect: DMSO Interaction with Human Nerve Growth Factor and Its Implications for Drug Discovery},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30143030}
}
EUVIMED